Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-Vivo Activated T-Cell Depletion to Prevent GVHD

NCT00594308 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT00594308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00594308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-Vivo Activated T-Cell Depletion to Prevent GVHD
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2007
Completion date
Not reported
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, hodgkin's disease, lymphoma, non-hodgkin's, mantle-cell lymphoma, multiple myeloma, myelodysplasia, myelofibrosis